Pazopanib ( DrugBank: Pazopanib )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
227	オスラー病	2

227. オスラー病

---

臨床試験数 : 54 /  薬物数 : 73 - (DrugBank : 21) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 136

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03850964 (ClinicalTrials.gov)	September 2019	12/2/2019	Pazopanib Effects on Bleeding in Hereditary Hemorrhagic Telangiectasia	Randomized Double Blind Study to Evaluate the Effect of Low Dose Pazopanib on Bleeding Due to Hereditary Hemorrhagic Telangiectasia	Hereditary Hemorrhagic Telangiectasia;Epistaxis Nosebleed;Anemia	Drug: Pazopanib;Drug: Placebo oral capsule	Cure HHT	NULL	Not yet recruiting	18 Years	75 Years	All	45	Phase 2/Phase 3	NULL
2	NCT03850730 (ClinicalTrials.gov)	September 2019	12/2/2019	Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia	An Open-label, Non-randomized Study of the Efficacy of Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)	Hereditary Hemorrhagic Telangiectasia;Epistaxis	Drug: Pazopanib	Cure HHT	University of North Carolina	Not yet recruiting	18 Years	75 Years	All	30	Phase 1/Phase 2	NULL